NCT06927856Recruiting
The Test-to-PrEP Study
Test-to-PrEP: A Randomized Hybrid Implementation/Effectiveness Trial of a Social Network Strategy to Increase Equitable Reach of HIV Testing and PrEP Information
Source: ClinicalTrials.gov · Last updated 27 Apr 2026
Brief summary (registry, in English)
To compare the effectiveness of two social network strategies (direct distribution and referral-based distribution) in increasing HIV self-testing (HIVST) completion rates among social network contacts of current Pre-Exposure Prophylaxis (PrEP) clients.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 320 (estimated)
- First submitted
- 7 Apr 2025
- Start date
- 10 Apr 2025
- Primary completion date
- 1 Jul 2028
- Lead sponsor
- University of Miami
- Diseases
- HIV
- NCT number
- NCT06927856
What you commit to
- Study type: Interventional
- Planned participants: 320
- From 10 Apr 2025 to the primary completion date, 1 Jul 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Inability to identify members of their social network who may benefit from receiving an HIVST kit and PrEP information.
- Failure to provide electronic informed consent prior to starting QR-linked Alter survey tools.
Other illness
- Inability or refusal to provide informed consent (e.g., cognitive impairment).
Age
- Aged 17 years or younger.
- Age 17 years or younger.
Other
- Unable or unwilling to comply with study procedures per study investigator
Who the study is looking for
- Stated willingness to provide informed consent.
- Stated willingness to comply with all study procedures.
- Stated availability for the duration of the study.
- Ability to identify members of their social network who may benefit from receiving an HIVST kit and PrEP information.
- Currently prescribed PrEP by RAPID clinics, including those initiating PrEP on the same day as study enrollment.
- \- Provision of electronic informed consent prior to completion of the Quick Response (QR)-linked survey instruments.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Miami Coordinator of this site? Confirm its status | Miami | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.